Are you Dr. Mejia Oneto?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
701 Sunrise Ave
Roseville, CA 95661Phone+1 916-791-1300Fax+1 916-734-7904
Summary
- Dr. Jose Mejia Oneto, MD is a family physician in Roseville, California. He is currently licensed to practice medicine in California.
Education & Training
University of Minnesota Medical SchoolClass of 2010
Certifications & Licensure
CA State Medical License 2011 - 2025
Publications & Presentations
PubMed
- Bio-Orthogonal Chemistry and Reloadable Biomaterial Enable Local Activation of Antibiotic Prodrugs and Enhance Treatments againstMagdalena Czuban, Magdalena Czuban, Magdalena Czuban, Sangeetha Srinivasan, Sangeetha Srinivasan
ACS central science. 2019-01-17 - In Vivo Bioorthogonal Chemistry Enables Local Hydrogel and Systemic Pro-Drug To Treat Soft Tissue Sarcoma.Jose M M Mejia Oneto, Irfan Khan, Leah Seebald, Maksim Royzen
ACS central science. 2016-08-10 - 22 citationsImplantable biomaterial based on click chemistry for targeting small molecules.José M. Mejía Oneto, Munish C. Gupta, J. Kent Leach, Mark A Lee, Julie L. Sutcliffe
Acta Biomaterialia. 2014-12-01
Grant Support
- Antigen-targeted activation of Topo1 inhibitors via click chemistrySHASQI, INC.2024–2026
- Antigen-targeted activation of Topo1 inhibitors via click chemistrySHASQI, INC.2024–2026
- Antibody-guided localized activation of bioorthogonal protodrugs via click chemistrySHASQI, INC.2023–2025
- Antibody-guided localized activation of bioorthogonal protodrugs via click chemistrySHASQI, INC.2023–2025
- Assessing the safety and efficacy of SQ3370 in a phase 1b dose-expansion cohort at the recommended Phase 2 dose in patients with advanced sarcomaSHASQI, INC.2021–2025
